Edesa Biotech Ownership | Who Owns Edesa Biotech?
Edesa Biotech Ownership Summary
Edesa Biotech is owned by 10.00% institutional investors, and 90.00% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.48% of its assets in Edesa Biotech shares.
EDSA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Edesa Biotech | 10.00% | - | 90.00% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Institutional Extnd Mkt Idx Tr | 15.70K | 0.48% | - |
Fidelity Extended Market Index | 13.35K | 0.41% | 1.82K |
DFA US Micro Cap I | 7.91K | 0.24% | - |
DFA US Core Equity 2 I | 3.42K | 0.11% | - |
Fidelity Series Total Market Index | 3.06K | 0.09% | 980.00 |
Fidelity Nasdaq Composite Index | 2.83K | 0.09% | - |
NT Ext Equity Mkt Idx Fd - L | 1.93K | 0.06% | - |
Northern Trust Extended Eq Market Idx | 1.93K | 0.06% | - |
NT Ext Equity Mkt Idx Fd - NL | 1.24K | 0.04% | - |
Fidelity Total Market Index | 1.20K | 0.04% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 25, 2024 | Nijhawan Pardeep | Chief Executive Officer | Buy | $20.00K |
Jan 10, 2023 | van der Velden Peter | - | Sell | $367.39K |
Jan 09, 2023 | van der Velden Peter | - | Sell | $32.70K |
Jan 10, 2023 | van der Velden Peter | - | Sell | $33.97K |
Jan 09, 2023 | van der Velden Peter | - | Sell | $353.65K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | 1 | - |
2023 Q3 | - | - |
EDSA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools